Australia - angielski - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - candesartan cilexetil, quantity: 8 mg - tablet, uncoated - excipient ingredients: magnesium stearate; carmellose calcium; hyprolose; macrogol 8000; maize starch; lactose monohydrate; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - candesartan cilexetil, quantity: 4 mg - tablet, uncoated - excipient ingredients: hyprolose; magnesium stearate; carmellose calcium; macrogol 8000; maize starch; lactose monohydrate; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - candesartan cilexetil, quantity: 32 mg - tablet, uncoated - excipient ingredients: magnesium stearate; maize starch; hyprolose; carmellose calcium; macrogol 8000; lactose monohydrate; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: maize starch; macrogol 8000; hyprolose; magnesium stearate; carmellose calcium; lactose monohydrate; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - candesartan cilexetil -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - candesartan cilexetil -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - candesartan cilexetil -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - candesartan cilexetil -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - candesartan cilexetil -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - candesartan cilexetil; hydrochlorothiazide -